Press Release

DURHAM, N.C., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel antivirals in areas of high unmet medical need, today announced that it will host a live conference call and audio webcast on Monday, August 8, 2016 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2016, and to provide a business overview.

To access the live conference call, please dial (877) 354-4056 (domestic) or (678) 809-1043 (international) at least five minutes prior to the start time, and refer to conference ID 49760359. A live audio webcast of the call will also be available on the Investors' section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.

About Chimerix
Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing novel antivirals in areas of high unmet medical need. Chimerix's proprietary lipid conjugate technology has produced brincidofovir (BCV, CMX001); CMX157, which was licensed to ContraVir Pharmaceuticals in 2014; and earlier-stage clinical candidates, including CMX669. For further information, please visit Chimerix's website, www.chimerix.com.

CONTACT:

Investor Relations:



ir@chimerix.com

or

Jesse Baumgartner

Stern Investor Relations

Jesse@sternir.com

212-362-1200



Media:



Becky Vonsiatsky

W2O Groupbvonsiatsky@w2ogroup.com

413-478-2003

News Provided by Acquire Media